FBN1 Marfan Syndrome Test

The document outlines a Statement of Work (SOW) regarding the FBN1 (Marfan Syndrome) single gene analysis contract for the Pittsburgh VA Medical Center. The purpose is to secure services for analyzing the FBN1 gene to confirm diagnoses of Marfan Syndrome through genetic testing. The contract covers all associated costs, including necessary consumables and reflex testing materials. The vendor must provide timely delivery of testing results, which will be communicated solely to the designated testing supervisor at the VA. Performance monitoring will be conducted by the VA supervisor to ensure compliance with contract terms, while security protocols mandate the appropriate handling of sensitive information. No government-furnished equipment or information is required for this contract. The analysis is a one-time purchase, with items ordered as needed and delivery scheduled within 14 days. This SOW reflects the VA’s commitment to providing accurate diagnostic services for genetic disorders, ensuring necessary protocols are met for patient care and data security.